Search results
Earnings call: Johnson & Johnson posts solid Q1 growth, eyes M&A strategy By Investing.com
Investing.com· 1 week agoJohnson & Johnson (JNJ (NYSE:JNJ)), a global healthcare giant, reported a 3.9% increase in worldwide...
Colleges backtrack as COVID vaccine mandate lawsuits proceed under SCOTUS mootness doctrine
Just the News· 2 weeks agoRutgers, The State University of New Jersey, told its campuses this month to fuggedaboudit when it...
Johnson & Johnson posts mixed results, narrows full-year guidance
Investing.com· 1 week agoJohnson & Johnson posts mixed results, narrows full-year guidance
Uveitis History Linked to Recurrence After COVID Vaccination
MedPage Today· 1 day agoThe risk was especially high in the initial 30 days after the first shot as compared with the...
List of Eligible Groups for COVID-19 Vaccine Expands March 15 & 29
New Jersey Business Magazine· 2 weeks agoGov. Phil Murphy today announced that the ranks of eligible groups who can receive COVID-19 vaccines...
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week ago&A. To ensure we provide enough time to address your questions, we anticipate the webcast will last...
Johnson & Johnson (JNJ) Q1 Earnings: Aligns with EPS Projections, Reports Sales Growth
GuruFocus.com via Yahoo Finance· 1 week agoOperational Sales Drivers: Excluding the COVID-19 Vaccine, operational sales saw a robust growth of 7.7%, driven by key pharmaceutical ...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 1 week agoIndependent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and...
Were COVID-19 Vaccines to Blame for Infertility? Heart Attacks? A New Report Weighs In
US News & World Report· 1 week agoThe Moderna and Pfizer COVID-19 vaccines can cause myocarditis but evidence suggests they don’t cause infertility, Guillain-Barré syndrome ...
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
Zacks via Yahoo Finance· 1 week agoJohnson & Johnson’s JNJ first-quarter 2024 earnings came in at $2.71 per share, which beat the Zacks...